Structural Basis for the Inhibition of RNase H Activity of HIV-1 Reverse Transcriptase by RNase H Active Site-Directed Inhibitors

HIV/AIDS continues to be a menace to public health. Several drugs currently on the market have successfully improved the ability to manage the viral burden in infected patients. However, new drugs are needed to combat the rapid emergence of mutated forms of the virus that are resistant to existing t...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Su, Hua-Poo, Yan, Youwei, Prasad, G. Sridhar, Smith, Robert F., Daniels, Christopher L., Abeywickrema, Pravien D., Reid, John C., Loughran, H. Marie, Kornienko, Maria, Sharma, Sujata, Grobler, Jay A., Xu, Bei, Sardana, Vinod, Allison, Timothy J., Williams, Peter D., Darke, Paul L., Hazuda, Daria J., Munshi, Sanjeev
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society for Microbiology (ASM) 2010
Pynciau:
Vaccines and Antiviral Agents
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2897604/
https://ncbi.nlm.nih.gov/pubmed/20484498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00353-10
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg